Prisms, Vision Therapy Reduce AACE - Takeaways - MDSpire

Prisms, Vision Therapy Reduce AACE

Retrospective cohort shows 79% of patients improved without surgery, with measurable gains in divergence and reduced esodeviation

  • By

  • Julie Greenbaum

  • March 5, 2026

  • 4 min

Share

  • 1

    Non-surgical management with prisms and vision therapy improved divergence amplitudes and reduced esodeviation in 79% of AACE patients.

  • 2

    The study evaluated 34 patients with acute acquired comitant esotropia, focusing on those with non-accommodative, non-neurologic types.

  • 3

    After therapy, distance esodeviation decreased by a median of 7 prism diopters, and divergence amplitudes increased by about 7 prism diopters.

  • 4

    Patients with esodeviation of 20 PD or less were often managed with vision therapy alone, while larger deviations required combined treatment.

  • 5

    The study highlighted limitations such as its retrospective design and lack of a control group, emphasizing the need for further research.

Original Source(s)

Prisms, Vision Therapy Reduce AACE

  • by Julie Greenbaum

  • March 5, 2026

Related Content

Monaco Event Explores Changes in Vision Care

EssilorLuxottica meeting covered advances in AI, diagnostics, and connected eyewear

  • May 4, 2026

  • 2 min
The Myopia Control Kit

Thomas Aller, OD, provides in-depth overviews of each myopia management option—pharmacologic therapy, soft contact lenses, orthokeratology, spectacle lenses, and environmental and behavioral interventions—so clinicians can not only provide the right option to each patient, but also address the larger economic and societal burdens of myopia.

Beyond the Diopter: Evolving Your Framework for Refractive Surgery Planning

Corneal health, axial length, and long-term ocular preservation are helpful guides for every refractive conversation